Cite
Pilichowska M, Pittaluga S, Ferry JA, et al. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv. 2017;1(26):2600-2609doi: 10.1182/bloodadvances.2017009472.
Pilichowska, M., Pittaluga, S., Ferry, J. A., Hemminger, J., Chang, H., Kanakry, J. A., Sehn, L. H., Feldman, T., Abramson, J. S., Kritharis, A., Hernandez-Ilizaliturri, F. J., Lossos, I. S., Press, O. W., Fenske, T. S., Friedberg, J. W., Vose, J. M., Blum, K. A., Jagadeesh, D., Woda, B., Gupta, G. K., Gascoyne, R. D., Jaffe, E. S., & Evens, A. M. (2017). Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood advances, 1(26), 2600-2609. https://doi.org/10.1182/bloodadvances.2017009472
Pilichowska, Monika, et al. "Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL." Blood advances vol. 1,26 (2017): 2600-2609. doi: https://doi.org/10.1182/bloodadvances.2017009472
Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK, Gascoyne RD, Jaffe ES, Evens AM. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv. 2017 Dec 11;1(26):2600-2609. doi: 10.1182/bloodadvances.2017009472. eCollection 2017 Dec 12. PMID: 29296913; PMCID: PMC5728632.
Copy
Download .nbib